Prevalence of CTX-M resistance marker and integrons among Escherichia coli and Klebsiella pneumoniae isolates of clinical origin

Letters in Applied Microbiology

Volumn 62, Issue 5, 2016, Pages 419-427

  Shaikh, S ^a   Rizvi, S M D ^a   Anis, R ^a   Shakil, S ^b  

^a INTEGRAL UNIVERSITY   (India)

^b KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

Escherichia coli; Klebsiella pneumoniae; Class 1 integrons; CTX M beta lactamases; ERIC PCR; Genotypic method

Indexed keywords

ANTIBIOTICS; GENES;

BACTERIAL PATHOGENS; CEFOTAXIME; CLASS 1 INTEGRONS; CTX-M BETA-LACTAMASE; E. COLI; ENTEROBACTERIAL REPETITIVE INTERGENIC CONSENSUS-PCR; GENOTYPIC METHOD; INTEGRONS; KLEBSIELLA PNEUMONIAE; LACTAMASES;

ESCHERICHIA COLI;

BACTERIAL DNA; BETA LACTAMASE CTX M; CEFOTAXIME; CEFTAZIDIME; REPETITIVE DNA; BETA LACTAMASE; BETA-LACTAMASE CTX-M, E COLI; ESCHERICHIA COLI PROTEIN;

ANTIBIOTIC RESISTANCE; BACTERIUM; BIOLOGICAL METHOD; ENZYME ACTIVITY; GENETIC MARKER; PATHOGEN; POLYMERASE CHAIN REACTION;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM CONJUGATION; BACTERIUM DETECTION; BACTERIUM ISOLATE; CONTROLLED STUDY; ENTEROBACTERIAL REPETITIVE INTERGENIC CONSENSUS POLYMERASE CHAIN REACTION; ESCHERICHIA COLI; GENETIC VARIABILITY; INT1 GENE; INTEGRON; KLEBSIELLA PNEUMONIAE; MOLECULAR TYPING; NONHUMAN; POLYMERASE CHAIN REACTION; PREVALENCE; SUL1 GENE; DRUG EFFECTS; ESCHERICHIA COLI INFECTION; GENETICS; HUMAN; ISOLATION AND PURIFICATION; KLEBSIELLA INFECTION; MICROBIOLOGY; MOLECULAR GENETICS; MULTIDRUG RESISTANCE;

BACTERIA (MICROORGANISMS); ENTEROBACTERIACEAE; ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE;

BETA-LACTAMASES; CEFOTAXIME; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; HUMANS; INTEGRONS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MOLECULAR SEQUENCE DATA; MOLECULAR TYPING; PREVALENCE;

EID: 84963525438     PISSN: 02668254     EISSN: 1472765X     Source Type: Journal    
DOI: 10.1111/lam.12567     Document Type: Article

References (42)

1. Agodi, A., Sciacca, A., Campanile, F. et al. (2000) Molecular epidemiology of Pseudomonas aeruginosa from cystic fibrosis in Sicily: genome macro restriction analysis and rapid PCR-ribotyping. New Microbiol 23, 319-327.
2. Al Hashem, G., Al Sweih, N., Jamal, W. and Rotimi, V.O. (2011) Sequence analysis of bla(CTX-M) genes carried by clinically significant Escherichia coli isolates in Kuwait hospitals. Med Princ Pract 20, 213-219.
3. Al-Marzooq, F., Mohd Yusof, M.Y. and Tay, S.T. (2015) Molecular analysis of antibiotic resistance determinants and plasmids in Malaysian isolates of multidrug resistant Klebsiella pneumoniae. PLoS ONE 10, e0133654.
4. Bhattacharjee, A., Sen, M.R., Prakash, P., Gaur, A., Anupurba, S. and Nath, G. (2010) Observation on integron carriage among clinical isolates of Klebsiella pneumoniae producing extended spectrum Beta-lactamases. Ind J Med Microbiol 28, 207-210.
5. Bonnet, R. (2004) Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes. Antimicrob Agents Chemother 48, 1-14.
6. CTX-M genes in clinical isolates of Escherichia coli and Klebsiella pneumoniae from Northeast India. Indian J Pathol Microbiol 57, 249-254.
7. Chu, C., Wong, D.W., Wang, M.H. et al. (2009) Genotyping, plasmid analysis, and antimicrobial susceptibility of Salmonella enterica serotype Enteritidis isolates from humans and chickens in central Taiwan. J Formos Med Assoc 108, 765-771.
8. Cowan, S.F. and Steel, K.J. (1970) Manual for the Identification of the Medical Bacteria. Cambridge: Cambridge University Press.
9. Curran, B., Jonas, D., Grundmann, H. et al. (2004) Development of a multilocus sequence typing scheme for the opportunistic pathogen Pseudomonas aeruginosa. J Clin Microbiol 42, 5644-5649.
10. Davies, J. and Davies, D. (2010) Origins and evolution of antibiotic resistance. Microbiol Mol Biol Rev 74, 417-433.
11. Doi, Y., Yokoyama, K., Yamane, K. et al. (2004) Plasmid mediated 16S rRNA methylase in Serratia marcescens conferring high level resistance to aminoglycosides. Antimicrob Agents Chemother 48, 491-496.
12. Eckert, C., Gautier, V. and Arlet, G. (2006) DNA sequence analysis of the genetic environment of various blaCTX-M genes. J Antimicrob Chemother 57, 14-23.
13. Gray, K.J., Wilson, L.K., Phiri, A. et al. (2006) Identification and characterization of ceftriaxone resistance and extended-spectrum b-lactamases in Malawian bacteraemic Enterobacteriaceae. J Antimicrob Chemother 57, 661-665.
14. Guerra, B., Soto, S., Cal, S. et al. (2000) Antimicrobial resistance and spread of class 1 integrons among Salmonella serotypes. Antimicrob Agents Chemother 44, 2166-2169.
15. Guimarãesa, A.S., Dornelesa, E.M.S., Andrade, G.I., Lage, A.P., Miyoshib, A., Azevedob, V., Gouveia, A.M.G. and Heinemann, M.B. (2011) Molecular characterization of Corynebacterium pseudotuberculosis isolates using ERIC-PCR. Vet Microbiol 153, 299-306.
16. Hawser, S.P., Bouchillon, S.K., Hoban, D.J., Badal, R.E., Hsueh, P.R. and Paterson, D. (2009) Emergence of high levels of extended spectrum b-lactamase-producing Gram-negative bacilli in Asia/Pacific: data from SMART 2007. Antimicrob Agents Chemother 53, 3280-3284.
17. Heffernan, H.M., Woodhouse, R.E., Pope, C.E. and Blackmore, T.K. (2009) Prevalence and types of extended-spectrum beta-lactamases among urinary Escherichia coli and Klebsiella spp. in New Zealand. Int J Antimicrob Agents 34, 544-549.
18. Jesus, R., Maria, D.N., Luisa, R. et al. (2004) Epidemiology and clinical features of infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in non-hospitalized patients. J Clin Microbiol 42, 1089-1094.
19. Kersulyte, D., Struelens, M.J., Deplano, A. and Berg, D.E. (1995) Comparison of arbitrarily primed PCR and macro restriction (pulsed-field gel electrophoresis) typing of Pseudomonas aeruginosa strains from cystic fibrosis patients. J Clin Microbiol 33, 2216-2219.
20. Khanna, N., Boyes, J., Lansdell, P.M., Hamouda, A. and Amyes, S.G. (2012) Molecular epidemiology and antimicrobial resistance pattern of extended-spectrum-beta-lactamase-producing Enterobacteriaceae in Glasgow, Scotland. J Antimicrob Chemother 67, 573-577.
21. Khemtong, S. and Chuanchuen, R. (2008) Class 1 integrons and Salmonella genomic island 1 among Salmonella enterica isolated from poultry and swine. Microb Drug Resist 14, 65-70.
22. Kim, J., Lim, Y.M., Jeong, Y.S. and Seol, S.Y. (2005) Occurrence of CTX-M-3, CTX-M-15, CTX-M-14, and CTX-M-9 extended-spectrum β-lactamases in Enterobacteriaceae clinical isolates in Korea. Antimicrob Agents Chemother 49, 1572-1575.
23. Krishnamurthy, V., Vijaykumar, G.S., Kumar, S.M., Prashanth, H.V., Prakash, R. and Nagaraj, E.R. (2013) Phenotypic and genotypic methods for detection of extended spectrum β lactamase producing Escherichia coli and Klebsiella pneumoniae isolated from ventilator associated pneumonia. J Clinical Diag Research 7, 1975-1978.
24. Lee, H., Yong, D., Yum, J.H. et al. (2006) Dissemination of 16S rRNA methylase-mediated highly amikacin-resistant isolates of Klebsiella pneumoniae and Acinetobacter baumannii in Korea. Diagn Microbiol Infect Dis 56, 305-312.
25. Li, B., Yi, Y., Wang, Q., Woo, P.C., Tan, L., Jing, H. et al. (2012) Analysis of drug resistance determinants in Klebsiella pneumoniae isolates from a tertiary-care hospital in Beijing, China. PLoS ONE 7, e42280.
26. Lin, C.F., Hsu, S.K., Chen, C.H., Huang, J.R. and Lo, H.H. (2010) Genotypic detection and molecular epidemiology of extended-spectrum b-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a regional hospital in central Taiwan. J Medical Microbiol 59, 665-671.
27. Loncaric, I., Stalder, G.L., Mehinagic, K., Rosengarten, R., Hoelzl, F., Knauer, F. and Walzer, C. (2013) Comparison of ESBL-and AmpC producing Enterobacteriaceae and methicillin-resistant Staphylococcus aureus (MRSA) isolated from migratory and resident population of rooks (Corvus frugilegus) in Austria. PLoS ONE 8, e84048.
28. Marcade, G., Deschamps, C., Boyd, A., Gautier, V., Picard, B., Branger, C., Denamur, E. and Arlet, G. (2009) Replicon typing of plasmids in Escherichia coli producing extended-spectrum β-lactamases. J Antimicrob Chemother 63, 67-71.
29. Marra, A.R., Pereira, C.A.P., Castelo, A., de Carmo Fihlo, J.R., Cal, R.G.R., Sader, H.S. and Wey, S.B. (2006) Health and economic outcomes of detection of Klebsiella pneumoniae-produced extended-spectrum B-lactamase (ESBL) in a hospital with high prevalence of this infection. Int Infect Dis 10, 56-60.
30. Renders, N., Romling, U., Verbrug, H. and Van Belkum, A. (2001) Comparative typing of Pseudomonas aeruginosa, by random amplification of polymorphic DNA or pulsed field gel electrophoresis of DNA macro restriction fragments. J Clin Microbiol 34, 3190-3195.
31. Robberts, F.J., Kohner, P.C. and Patel, R. (2009) Unreliable extended-spectrum beta-lactamase detection in the presence of plasmid-mediated AmpC in Escherichia coli clinical isolates. J Clin Microbiol 47, 358-361.
32. Rossolini, G.M., Andrea, M.M. and Mugnaiolic, C. (2008) The spread of CTX-M type extended spectrum β-lactamases. Clin Microbial Infect 14, 33-41.
33. Sandegren, L., Linkevicius, M., Lytsy, B., Melhus, A. and Andersson, D.I. (2012) Transfer of an Escherichia coli ST131 multi resistance cassette has created a Klebsiella pneumoniae-specific plasmid associated with a major nosocomial outbreak. J Antimicrob Chemother 67, 74-83.
34. Shahcheraghi, F., Noveiri, H. and Nasiri, S. (2007) Detection of bla TEM and bla SHVgenes among clinical isolates of E. coli from Tehran hospitals. Iran J Med Microbiol 1, 1-8.
35. Shaikh, S., Fatima, J., Shakil, S., Rizvi, S.M.D. and Kamal, M.A. (2015) Risk factors for acquisition of extended spectrum beta lactamase producing Escherichia coli and Klebsiella pneumoniae in North-Indian hospitals. Saudi J Biol Sciences 22, 37-41.
36. Shakil, S., Akram, M., Ali, S.M. and Khan, A.U. (2010) Acquisition of extended-spectrum b-lactamase producing Escherichia coli strains in male and female infants admitted to a neonatal intensive care unit: molecular epidemiology and analysis of risk factors. J Medical Microbiol 59, 948-954.
37. Spencer, D. (1999) Clinical outcome in relation to care in centres specializing in cystic fibrosis. Cross infection with Pseudomonas aeruginosa is unusual. Brit Med 318, 58.
38. Spencker, F.B., Haupt, S., Claros, M.C. et al. (2000) Epidemiologic characterization of Pseudomonas aeruginosa in patients with cystic fibrosis. Clin Microbiol Infect 6, 600-607.
39. Versalovic, J., Koeuth, T. and Lupski, J.R. (1991) Distribution of repetitive DNA sequences in eubacteria and application to fingerprinting of bacterial genomes. Nucleic Acids Res 19, 6823-6831.
40. Villa, L., Garcia-Fernandez, A., Fortini, D. and Carattoli, A. (2010) Replicon sequence typing of IncF plasmids carrying virulence and resistance determinants. J Antimicrob Chemother 65, 2518-2529.
41. Wang, G., Huang, T., Surendraiah, P.K.M., Wang, K., Komal, R., Zhuge, J., Chern, C., Kryszuk, A.A. et al. (2013) CTX-M β-Lactamase-producing Klebsiella pneumoniae in Suburban New York, New York, USA. Emerg Infect Dis 19, 1803-1810.
42. Yan, W., Shi, L., Jia, W.X. et al. (2005) Evaluation of the biofilm forming ability and genetic typing for clinical isolates of Pseudomonas aeruginosa by enterobacterial repetitive intergenic consensus based PCR. Microbiol Immunol 49, 1057-1061.